Entrada Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:TRDA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 526.32 M486.48 M448.78 M412.9 M377.38 M335.52 M 負債合計 97.64 M69.22 M69.28 M72.18 M71.25 M64.66 M 純資産合計 428.68 M417.26 M379.5 M340.72 M306.13 M270.85 M 負債および純資産合計 526.32 M486.48 M448.78 M412.9 M377.38 M335.52 M 有利子負債合計 —————— 純負債 ——————

ニュース

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

ダウが350ポイント下落、USフーズが悲観的な決算を発表

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

【決算速報】Entrada Therapeutics、売上高は予想を下回り、利益は予想を上回る結果に

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?